Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virtual screening of virtual libraries.

Darren V S Green1

  • 1GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.

Progress in Medicinal Chemistry
|May 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing Predictive Models by Sharing Predictions - An Investigation of a Federated Learning Approach for ADMET Predictions.

Journal of medicinal chemistry·2026
Same author

Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 Inhibitors.

Journal of medicinal chemistry·2026
Same author

bbSelect - An Open-Source Tool for Performing a 3D Pharmacophore-Driven Diverse Selection of R-Groups.

Journal of chemical information and modeling·2024
Same author

Search for relevant subsets of binary predictors in high dimensional regression for discovering the lead molecule.

Pharmaceutical statistics·2021
Same author

MAIP: a web service for predicting blood-stage malaria inhibitors.

Journal of cheminformatics·2021
Same author

A Turing Test for Molecular Generators.

Journal of medicinal chemistry·2020
Same journal

Preface.

Progress in medicinal chemistry·2025
Same journal

The rise of AlphaFold in drug design.

Progress in medicinal chemistry·2025
Same journal

Drug design strategies for the selective targeting of lung, liver and kidney.

Progress in medicinal chemistry·2025
Same journal

To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives.

Progress in medicinal chemistry·2024
Same journal

Another decade of antimalarial drug discovery: New targets, tools and molecules.

Progress in medicinal chemistry·2024
Same journal

Harnessing conformational drivers in drug design.

Progress in medicinal chemistry·2024
See all related articles

Virtual screening of virtual libraries (VSVL) offers unparalleled potential for drug discovery by screening vast molecular datasets. Despite challenges, technological advancements promise more efficient drug candidate development.

Area of Science:

  • Computational chemistry and cheminformatics
  • Drug discovery and development
  • Bioinformatics and computational biology

Background:

  • Virtual screening of virtual libraries (VSVL) is a rapidly evolving field with significant research efforts in algorithms and infrastructure.
  • Despite high-quality work, the literature shows a limited number of successful examples, partly due to the long lead times in drug discovery.
  • The scientific community's focus and the emergence of specialized startups indicate the underlying success and potential of VSVL.

Purpose of the Study:

  • To highlight the unique capabilities of VSVL in exploring vast chemical spaces (>10^30 molecules).
  • To discuss the challenges hindering the widespread adoption and development of VSVL methods.
  • To emphasize the synergistic potential of integrating VSVL with other mature technologies for improved drug discovery outcomes.

Related Experiment Videos

Main Methods:

  • VSVL methods are capable of evaluating extremely large compound libraries (e.g., 10^13 compounds), far exceeding high-throughput screening.
  • The study emphasizes the need for confidence in exploiting VSVL, committing synthesis based on its predictions, and integrating it into medicinal chemistry strategies.
  • Overcoming the daunting nature of these tools for bench scientists requires accessible, robust end-user software that maintains scientific integrity.

Main Results:

  • VSVL presents a unique advantage for lead generation, lead hopping, and optimizing potency and ADME properties.
  • The scarcity of literature data is a significant impediment to advancing VSVL methodologies.
  • A convergence of mature technologies, including predictive computational chemistry, advanced algorithms, high-throughput crystallography, ADME measurements, and distributed computing, creates a powerful synergy.

Conclusions:

  • The integration of VSVL with other cutting-edge technologies is poised to revolutionize the pharmaceutical industry.
  • This synergy will lead to more efficient production of higher-quality clinical candidates.
  • The future of drug discovery is increasingly virtual, driven by the advancements and integration of computational methods.